Search results
New COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Headset making you sick? Here's an unlikely cure for VR-induced nausea
ZDNet· 13 hours agoIt may sound like something out of a surrealist's handbook or a propaganda campaign by Enya fans –...
How Long Should I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 1 day agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
9 Ways You Can Loosen a Bowel Blockage at Home
Health.com· 17 hours agoBowel blockages (also known as bowel or intestinal obstructions) occur when food cannot pass through your large or small intestines. This can cause...
Cucumbers Have Been Recalled In 14 States Due To Potential Salmonella Risk
Tasting Table via Yahoo News· 4 days agoThe U.S. FDA has announced a recall for whole cucumbers that are possibly contaminated with...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 2 days agoSide effects The two share some potential side effects. "Common side effects of metformin include...
Study finds the rate of withdrawal from quitting antidepressants
CNN via Yahoo News· 3 days agoRoughly 15% of participants who discontinued antidepressants experienced withdrawal symptoms such as...
Fewer people have symptoms after quitting antidepressants than previously thought
United Press International via Yahoo News· 1 day agoThese symptoms could include dizziness, headache, nausea, insomnia and irritability. Photo by Adobe...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoKaryopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary ...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
WCBD-TV Charleston· 11 hours agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational ...